title: Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.
abstract: HIV infection and methamphetamine (Meth) abuse both may lead to oxidative stress. This study used HIV-1 transgenic (HIV-1Tg) rats to investigate the independent and combined effects of HIV viral protein expression and low dose repeated Meth exposure on the glutathione (GSH)-centered antioxidant system and oxidative stress in the brain. Total GSH content, gene expression and/or enzymatic activities of glutamylcysteine synthetase (GCS), gamma-glutamyltransferase (GGT), glutathione reductase (GR), glutathione peroxidase (GPx), glutaredoxin (Glrx), and glutathione-s-transferase (GST) were measured. The protein expression of cystine transporter (xCT) and oxidative stress marker 4-hydroxynonenal (HNE) were also analyzed. Brain regions studied include thalamus, frontal and remainder cortex, striatum, cerebellum and hippocampus. HIV-1Tg rats and Meth exposure showed highly regional specific responses. In the F344 rats, the thalamus had the highest baseline GSH concentration and potentially higher GSH recycle rate. HIV-1Tg rats showed strong transcriptional responses to GSH depletion in the thalamus. Both HIV-1Tg and Meth resulted in decreased GR activity in thalamus, and decreased Glrx activity in frontal cortex. However, the increased GR and Glrx activities synergized with increased GSH concentration, which might have partially prevented Meth-induced oxidative stress in striatum. Interactive effects between Meth and HIV-1Tg were observed in thalamus on the activities of GCS and GGT, and in thalamus and frontal cortex on Glrx activity and xCT protein expression. Findings suggest that HIV viral protein and low dose repeated Meth exposure have separate and combined effects on the brain's antioxidant capacity and the oxidative stress response that are regional specific.
authors.affiliation: Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street BSB 222, Honolulu, HI 96813, USA.
authors.forename: Xiaosha
authors.initials: X
authors.lastname: Pang
authors.forename: Jun
authors.initials: J
authors.lastname: Panee
authors.forename: Xiangqian
authors.initials: X
authors.lastname: Liu
authors.forename: Marla J
authors.initials: MJ
authors.lastname: Berry
authors.forename: Sulie L
authors.initials: SL
authors.lastname: Chang
authors.forename: Linda
authors.initials: L
authors.lastname: Chang
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000821:virology; D015658:HIV Infections / Q000378:metabolism*; D015497:HIV-1; D007279:Injections, Subcutaneous; D008694:Methamphetamine / Q000008:administration & dosage*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D011916:Rats, Inbred F344; D055647:Rats, Transgenic
chemical_list: D000975:Antioxidants; D008694:Methamphetamine
references.citation: J Neurochem. 2002 Nov;83(4):955-63
references.pmid: 12421368
references.citation: J Pharmacol Sci. 2008 Nov;108(3):227-38
references.pmid: 19008644
references.citation: Brain Res. 2006 Dec 13;1125(1):163-70
references.pmid: 17112479
references.citation: J Neuroimmunol. 2010 Jan 25;218(1-2):94-101
references.pmid: 19913921
references.citation: J Membr Biol. 1986;89(1):1-8
references.pmid: 2870192
references.citation: J Neuroimmune Pharmacol. 2009 Sep;4(3):309-16
references.pmid: 19444617
references.citation: Science. 1983 Apr 29;220(4596):472-7
references.pmid: 6836290
references.citation: J Neuroimmune Pharmacol. 2007 Dec;2(4):319-28
references.pmid: 18040850
references.citation: Free Radic Biol Med. 2010 May 15;48(10):1388-98
references.pmid: 20188164
references.citation: J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):467-74
references.pmid: 14657756
references.citation: PLoS One. 2009 Dec 04;4(12):e8170
references.pmid: 19997643
references.citation: Neurosci Lett. 1997 Mar 14;224(2):119-22
references.pmid: 9086471
references.citation: Neurology. 2003 Jan 28;60(2):307-14
references.pmid: 12552050
references.citation: Biochim Biophys Acta. 2008 Oct;1778(10):2413-20
references.pmid: 18621020
references.citation: J Magn Reson Imaging. 2010 Nov;32(5):1045-53
references.pmid: 21031507
references.citation: Clin Exp Pharmacol Physiol. 1989 Nov;16(11):867-71
references.pmid: 2612064
references.citation: Neuromolecular Med. 2002;2(1):71-85
references.pmid: 12230306
references.citation: J Neurosci. 2008 Sep 17;28(38):9404-13
references.pmid: 18799673
references.citation: J Biol Chem. 2007 Aug 17;282(33):23759-65
references.pmid: 17526492
references.citation: Amino Acids. 2012 Jan;42(1):171-9
references.pmid: 21369940
references.citation: Free Radic Biol Med. 1999 Nov;27(9-10):922-35
references.pmid: 10569625
references.citation: J Subst Abuse Treat. 2002 Apr;22(3):149-56
references.pmid: 12039618
references.citation: Life Sci. 2009 Jul 3;85(1-2):1-10
references.pmid: 19345695
references.citation: PLoS One. 2008 Jun 18;3(6):e2459
references.pmid: 18560520
references.citation: Brain Res. 1998 Nov 30;813(1):200-2
references.pmid: 9824698
references.citation: Am J Psychiatry. 2005 Feb;162(2):361-9
references.pmid: 15677602
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13848-53
references.pmid: 20643942
references.citation: J Pharmacol Exp Ther. 1998 Oct;287(1):107-14
references.pmid: 9765328
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9271-6
references.pmid: 11481487
references.citation: Mol Aspects Med. 2009 Feb-Apr;30(1-2):86-98
references.pmid: 18812186
references.citation: Neuroscience. 1998 Feb;82(4):1213-23
references.pmid: 9466441
references.citation: Toxicol Appl Pharmacol. 2007 May 1;220(3):243-51
references.pmid: 17350664
references.citation: J Cereb Blood Flow Metab. 2011 Feb;31(2):486-93
references.pmid: 20664612
references.citation: Neurology. 2007 May 1;68(18):1481-7
references.pmid: 17470750
references.citation: Arch Biochem Biophys. 1970 May;138(1):177-88
references.pmid: 4392815
references.citation: Brain Res. 2012 Jan 6;1429:134-44
references.pmid: 22079322
references.citation: J Biol Chem. 2001 Jan 12;276(2):1335-44
references.pmid: 11035035
references.citation: Brain Res. 2009 Jun 12;1275:87-95
references.pmid: 19374890
references.citation: J Neurovirol. 2004 Dec;10(6):327-37
references.pmid: 15765804
references.citation: Exp Neurol. 1998 Dec;154(2):276-88
references.pmid: 9878167
references.citation: Anal Biochem. 2003 Jul 15;318(2):175-80
references.pmid: 12814619
references.citation: J Neuroimmunol. 2009 Jan 3;206(1-2):106-11
references.pmid: 19101040
references.citation: J Neuroimmune Pharmacol. 2010 Dec;5(4):566-73
references.pmid: 20532992
references.citation: J Psychoactive Drugs. 2002 Jul-Sep;34(3):295-300
references.pmid: 12422940
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 1;879(21):2005-9
references.pmid: 21665555
references.citation: Eur J Pharmacol. 2000 Jul 14;400(1):99-102
references.pmid: 10913590
references.citation: AIDS Res Hum Retroviruses. 2011 Feb;27(2):179-82
references.pmid: 20929344
references.citation: Public Health Rep. 2002;117 Suppl 1:S30-8
references.pmid: 12435825
references.citation: J Neurochem. 2011 Mar;116(6):1005-17
references.pmid: 21166679
references.citation: Clin Dev Immunol. 2012;2012:734125
references.pmid: 22242038
references.citation: Neurology. 1995 Sep;45(9):1678-83
references.pmid: 7675226
references.citation: J Neurochem. 2001 Oct;79(1):152-60
references.pmid: 11595767
references.citation: Brain Res Bull. 2008 Dec 16;77(6):361-6
references.pmid: 18852031
references.citation: Cell Death Differ. 2005 Aug;12 Suppl 1:893-904
references.pmid: 15761472
references.citation: CNS Neurol Disord Drug Targets. 2010 Jul;9(3):373-82
references.pmid: 20053169
references.citation: FASEB J. 2003 Apr;17(6):717-9
references.pmid: 12594173
references.citation: Methods Enzymol. 1981;77:237-53
references.pmid: 6120436
references.citation: Biochim Biophys Acta. 2009 Feb;1793(2):427-38
references.pmid: 19038292
references.citation: Chem Res Toxicol. 2002 Nov;15(11):1445-50
references.pmid: 12437335
references.citation: Amino Acids. 2012 Jan;42(1):231-46
references.pmid: 21409388
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):176-84
references.pmid: 15579295